Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Sex differences in autoimmune diseases.
Keystone Symposium: Neuroepigenetics
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Summit 2013 + Expo
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
T(H)17 cytokines in autoimmune neuro-inflammation.
Best practice in the use of natalizumab in multiple sclerosis.
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Environmental, modifiable risk factors for multiple sclerosis
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
National MS Society: Research Grants
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Management of worsening multiple sclerosis with mitoxantrone: a review.
Sex differences in autoimmune disease.
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »